These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 28449678

  • 1. [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.
    Justet A, Laurent-Bellue A, Thabut G, Dieudonné A, Debray MP, Borie R, Aubier M, Lebtahi R, Crestani B.
    Respir Res; 2017 Apr 27; 18(1):74. PubMed ID: 28449678
    [Abstract] [Full Text] [Related]

  • 2. The Value of 18F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients.
    Yoon HY, Lee SH, Ha S, Ryu JS, Song JW.
    J Korean Med Sci; 2021 Oct 25; 36(41):e257. PubMed ID: 34697928
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 25; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.
    Umeda Y, Demura Y, Morikawa M, Anzai M, Kadowaki M, Ameshima S, Tsuchida T, Tsujikawa T, Kiyono Y, Okazawa H, Ishizaki T, Ishizuka T.
    J Nucl Med; 2015 Dec 25; 56(12):1869-75. PubMed ID: 26359263
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 25; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
    Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, Kayani I, Menezes LJ, Dickson JC, Ell PJ.
    J Nucl Med; 2009 Apr 25; 50(4):538-45. PubMed ID: 19289428
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan 25; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is 18F-FDG PET/CT useful for the differential diagnosis of solitary pulmonary nodules in patients with idiopathic pulmonary fibrosis?
    Lee SH, Sung C, Lee HS, Yoon HY, Kim SJ, Oh JS, Song JW, Kim MY, Ryu JS.
    Ann Nucl Med; 2018 Aug 25; 32(7):492-498. PubMed ID: 29974372
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery.
    Yoon HY, Lee SH, Ha S, Ryu JS, Song JW.
    BMC Pulm Med; 2021 Sep 16; 21(1):294. PubMed ID: 34530787
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M, Chen Y, Huang H, Zhou X, Liu J, Huang G.
    Oncotarget; 2016 Dec 13; 7(50):83544-83553. PubMed ID: 27835875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.